Jessica Bridges Weaver named as a 2026 Women in Business award winner

Written by BioAgilytix

BioAgilytix (NC, USA) celebrates Scientific Officer Jessica Bridges Weaver being named as a 2026 Women in Business award winner by Triangle Business Journal.

With more than 20 years of experience across pharmaceutical manufacturing and analytical testing, Jessica has played a critical role in strengthening BioAgilytix’s scientific and regulatory leadership. In her role, she partners closely with global laboratory and business development teams to advise clients on phase-appropriate, regulatory-ready testing strategies for complex biologics. Her work extends to assay design and troubleshooting, ensuring methods align with both client objectives and evolving global regulatory expectations.

“It is truly an honor to be recognized alongside so many inspiring women,” expressed Weaver. “This recognition reflects the incredible teams I am privileged to work with at BioAgilytix and our shared commitment to advancing science, strengthening communities, and improving patients’ lives. I am grateful for the opportunity to contribute to work that creates meaningful impact for our clients and the broader life sciences community.”

Her impact has been especially evident in the strategic expansion of BioAgilytix’s CMC analytical testing services, as well as the global growth of GMP bioassay capabilities and the development of specialized infrastructure in Hamburg, Germany. Beyond operational leadership, Jessica is a recognized thought leader in CMC analytics and bioanalysis who produces and delivers webinars, conference presentations and peer-reviewed publications that promote continuous learning and knowledge-sharing across the life sciences community.


You may also be interested in:


In addition to her professional achievements, Jessica is deeply committed to community service and mentorship. She actively supports STEM education initiatives, mentors high school students and partners with organizations focused on pediatric care and child welfare. Her work reflects a lifelong commitment to stewardship, integrity and expanding access to opportunities for future generations.

Davide Molho, Chief Executive Officer of BioAgilytix, commented:

“Jessica exemplifies the scientific rigor, integrity and collaborative leadership that defines BioAgilytix. Her ability to translate complex science into meaningful impact for our clients and the industry makes her an outstanding leader and a deserving recipient of this recognition.”

Jessica’s recognition represents the strength of the BioAgilytix community, and a culture built on collaboration, integrity and scientific excellence.